This is likely one major reason that Immune Design's shares have zoomed up 184 percent less than four months after the company's late July IPO. The upside of success in the cancer fight, it goes without saying, is enormous. Who isn't eager to find a cure for cancer? That's the thrilling potential of this newly public biotech firm, which develops technologies that help the body's immune system produce cells that battle forms of the illness, in addition to other ailments. Regardless, on a fundamental basis GoPro is a popular, if niche, product, while the company's revenues are growing and its bottom line is well in the black. When secondary share issues are announced, a company's stock often takes a hit, since investors aren't too crazy about their existing stakes being diluted. It'll sell 10.3 million fresh shares on the market, adding to the nearly 126 million currently outstanding. until GoPro decided to float a secondary issue of stock. The stock recovered after the company reported strong third-quarter earnings, and all seemed well again. But then the camera was effectively blamed for the horrific accident that befell Formula One racing star Michael Schumacher - although the journalist making the allegation later recanted - and the shares cratered. GoPro's stock hit the market at the end of June priced at $24, and as if this writing it now stands at $70.72 for a muscular 195 percent total return.Īlthough that's impressive, it should be noted that the current price is quite a bit lower than the stock's high of nearly $94, which it touched in early October. In order of stock price appreciation, they are:Ģ014's current IPO front-runner is this company, maker of the popular action photography camera - the one that's usually responsible for those hairy point-of-view videos posted on Facebook ( FB) and other online sharing sites. Since we're heading into the most optimistic time of the year, we'll shine a light on the three best performers. Which is saying something: That was the height of the dot.com frenzy, when seemingly every new company with a website felt compelled to list on the stock exchange.Īs can be expected of a busy IPO year, some of 2014's new stock market titles have been runaway hits soaring above their issue price, while others have belly-flopped. In terms of proceeds raised from IPOs, 2014 will challenge or even exceed the year 2000. Now that it's nearly over, we can definitively say that 2014 has been one of the best years for initial public stock offerings in history.

Source ypos 2014